Anna Brunn

Kerpener St. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases.

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases.

Journal: Nature medicine

Published: June 20, 2025

The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse.

The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse.

Journal: Clinical nuclear medicine

Published: January 14, 2025

Biallelic CRELD1 variants cause severe muscle weakness and infantile epilepsy.

Biallelic CRELD1 variants cause severe muscle weakness and infantile epilepsy.

Journal: Brain communications

Published: November 05, 2024

Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis.

Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis.

Journal: Acta neuropathologica

Published: June 23, 2023

Diagnostic Accuracy of MR Spectroscopic Imaging and 18F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study.

Diagnostic Accuracy of MR Spectroscopic Imaging and 18F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: May 11, 2023

Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib.

Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib.

Journal: Neuro-oncology

Published: March 24, 2023

Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis.

Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis.

Journal: Journal of neurology

Published: March 20, 2023

Expression of Cas9 in a Syngeneic Model of Primary Central Nervous System Lymphoma Induces Intracerebral NK and CD8 T Cell-Mediated Lymphoma Cell Lysis Via Perforin.

Expression of Cas9 in a Syngeneic Model of Primary Central Nervous System Lymphoma Induces Intracerebral NK and CD8 T Cell-Mediated Lymphoma Cell Lysis Via Perforin.

Journal: The CRISPR journal

Published: October 19, 2022

Case report: Use of 68Ga-DOTATATE-PET for treatment guidance in complex meningioma disease.

Case report: Use of 68Ga-DOTATATE-PET for treatment guidance in complex meningioma disease.

Journal: Frontiers in oncology

Published: August 11, 2022

AMD3100-Mediated CXCR4 Inhibition Impairs Development of Primary Lymphoma of the Central Nervous System.

AMD3100-Mediated CXCR4 Inhibition Impairs Development of Primary Lymphoma of the Central Nervous System.

Journal: The American journal of pathology

Published: July 28, 2022

Persistent hypokalaemia and intermittent muscle weakness.

Persistent hypokalaemia and intermittent muscle weakness.

Journal: Practical neurology

Published: June 24, 2022

Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas.

Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas.

Journal: Journal of neuro-oncology

Published: May 12, 2022

Showing 1-12 of 64

Last Updated: 09/26/2026